# Tootsie Roll Industries Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Tootsie Roll Industries Inc](/companies/tr.md) (CIK 98677)
- Form: 10-Q
- Filed: 2021-05-05
- Accepted by EDGAR: May 5, 2021, 16:01 ET
- Period: 2021-03-31
- Accession: 0001558370-21-005899
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/98677/000155837021005899/tr-20210331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/98677/000155837021005899/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $103.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $66.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2021-01-01 to 2021-03-31 | $37.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $26.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $10.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $3.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $10.8m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.16 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $15.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $3.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $11.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2021-01-01 to 2021-03-31 | $7.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-03-31 | $136.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $292.3m | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $979.0m | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $65.9m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2021-03-31 | $758.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 25,390 characters.

This financial review discusses the Company’s financial condition, results of operations, liquidity and capital resources and other matters. Dollars are presented in thousands, except per share amounts. This review should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and related notes included in this Form 10-Q and with the Company’s Consolidated Financial Statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).

Net product sales were $101,795 in first quarter 2021 compared to $102,803 in first quarter 2020, a decrease of $1,008 or 1.0%. Domestic (U.S.) net product sales in first quarter 2021 declined 3.1% compared to the corresponding period in the prior year, however, foreign net product sales, including exports to foreign markets, increased compared to the corresponding period in the prior year. Although the Covid-19 pandemic continued to have some adverse effects on first quarter 2021 net sales, we are continuing to make progress as the economy “reopens”. In the first quarter 2021, the Covid-19 pandemic has continued to curtail and limit access to certain channels of trade where the Company has historically sold its products. Response to this pandemic has resulted in the disruption and changes in lifestyles, shopping habits, daily work routines, and consumer behaviors, all of which have adversely affected planned consumer purchases of the Company’s products for “sharing” and “give away” occasions. Many of the Company’s products are consumed at group events, outings, and other gatherings which have been significantly curtailed or in some cases eliminated due to concern of possible infection or spreading of the Covid-19 virus. Impulse purchases of Company products at retail outlets have also been adversely affected by these changes in consumer behavior. As the economy continues to “reopen” and these adverse effects subside, we have seen improvements in our sales and customer orders. Our second quarter 2021 customer order trend has shown favorable improvement compared to second quarter 2020 when the pandemic had a significant adverse effect on our sales.

Product cost of goods sold were $65,565 in first quarter 2021 compared to $66,443 in first quarter 2020. Product cost of goods sold includes $153 and $(319) of certain deferred compensation expenses (credits) in first quarter 2021 and 2020, respectively. These deferred compensation expenses (credits) principally result from the changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years and are not reflective of current operating results. Adjusting for the aforementioned, product cost of goods sold decreased from $66,762 in first quarter 2020 to $65,412 in first quarter 2021, a decrease of $1,350 or 2.0%. As a percentage of net product sales, adjusted product cost of goods sold was 64.3% and 64.9% in first quarter 2021 and 2020, respectively, a favorable decrease of 0.6 percentage points. Certain cost and expense reductions, which include Company initiatives to reduce costs, contributed to the reduction of adjusted product cost of goods sold as a percentage of net product sales The Company is focused on the longer term and therefore is continuing to make investments in plant manufacturing operations to meet new consumer and customer demands, achieve product quality improvements, increase operational efficiencies and provide value to consumers.

Selling, marketing and administrative expenses were $26,809 in first quarter 2021 compared to $16,272 in first quarter 2020. Selling, marketing and administrative expenses include $3,036 and $(9,056) of certain deferred compensation expenses (credits) in first quarter 2021 and 2020, respectively. As discussed above, these expenses principally result from changes in the market value of investments and investment income from trading securities relating to compensation deferred in previous years, and are not reflective of current operating results. Adjusting for the aforementioned deferred compensation expenses (credits), selling, marketing and administrative expenses decreased from $25,328 in first quarter 2020 to $23,773 in first quarter 2021, a decrease of $1,555 or 6.1%. As a percentage of net product sales, adjusted selling, marketing and administrative expenses decreased from 24.6% in first quarter 2020 to 23.4% in first quarter 2021, a favorable decrease of 1.2 percentage points as a percent of net product sales. The decrease in adjusted selling, marketing and administrative expenses as a percentage of net product sales in first quarter 2021 reflects the benefits of certain operational changes and expense reduction initiatives, as well as reduced business travel due to the Covid-19 pandemic. Selling, marketing and administrative expenses include $10,139 and $10,672 for customer freight, delivery and warehousing expenses in first quarter 2021 and 2020, respectively, a decrease of $533 or 5.0%. These expenses were 10.0% and 10.4% of net product sales in first quarter 2021 and 2020, respectively, which also contributed to the reduction in adjusted selling, marketing and administrative expenses as a percent of net product sales.

Earnings from operations were $10,410 in first quarter 2021 compared to $20,744 in first quarter 2020. Earnings from operations include $3,189 and $(9,375) of certain deferred compensation expenses (credits) in first quarter 2021 and 2020, respectively, which are discussed above. Adjusting for these deferred compensation costs, expenses and (credits), earnings from operations were $13,599 and $11,369 in first quarter 2021 and 2020, respectively, an increase of $2,230 or 19.6%. As a percentage of net product sales, these adjusted operating earnings were 13.4% and 11.1% in first quarter 2021 and 2020, respectively, a favorable increase of 2.3 percentage points. The increase in adjusted operating earnings in first quarter 2021 principally reflects the benefits of more favorable product cost of goods sold and related better gross profit margins, and reductions in selling, marketing and administrative expenses, excluding certain deferred compensation expenses (credits), as a percentage of net product sales as discussed above.

Management believes the comparisons presented in the preceding paragraphs, after adjusting for changes in deferred compensation, are more reflective of the underlying operations of the Company.

Other income (loss), net was $3,816 in first quarter 2021 compared to $(5,494) in first quarter 2020, a favorable increase of $9,310. Other income (loss), net for first quarter 2021 and 2020 includes net gains (losses) and investment income of $3,189 and $(9,375), respectively, on trading securities which provide an economic hedge of the Company’s deferred compensation liabilities. These changes in trading securities, including mutual fund investments in equity securities, reflect both the overall equity market downturn as of March 31, 2020 in response to Covid-19, and the overall equity market recovery as of March 31, 2021. These changes in market values were substantially offset by a like amount of deferred compensation expense (credits) included in product cost of goods sold and selling, marketing, and administrative expenses in the respective periods as discussed above. Other income (loss), net for first quarter 2021 and 2020 includes investment income on available for sale securities of $716 and $1,181 in 2021 and 2020, respectively. Other income (loss), net also includes pre-tax gains on foreign exchange of $33 and $2,510 in first quarter 2021 and 2020, respectively.

The consolidated effective tax rates were 24.3% and 21.5% in first quarter 2021 and 2020, respectively. Lower state income taxes contributed to the lower effective tax rate in first quarter 2020. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into U.S. law. The CARES Act has provided a substantial stimulus and assistance package intended to address the economic impact of the Covid-19 pandemic, including tax relief and government loans, grants and investments. The Canadian government also enacted a stimulus program, Canadian Emergency Wage Subsidy (“CEWS”), to respond to the economic impact of Covid-19 during 2020. The Company’s financial results in first quarter 2021 did reflect some very limited benefits from these government stimulus programs, however, no benefits were realized in first quarter 2020. The Company continues to monitor the effects and related benefits that may result from the above-discussed legislation, the American Rescue Plan Act of 2021 legislation passed in first quarter 2021, and other proposed and enacted stimulus legislation. Based on consultation with its tax advisors, the Company does not believe that it will be eligible for any significant benefits in 2021 under these stimulus programs.

Net earnings attributable to Tootsie Roll Industries, Inc. were $10,767 (after $4 net loss attributed to non-controlling interests) in first quarter 2021 compared to $11,982 (after $6 net loss attributed to non-controlling interests) in first quarter 2020, and earnings per share were $0.16 and $0.17 in first quarter 2021 and 2020, respectively, a decrease of $0.01 per share, or 5.9%. The prior year first quarter 2020 comparative net earnings benefitted from foreign exchange after-tax gains of approximately $1,900,000 ($2,510,000 pre- tax gain) or $0.03 per share, which significantly affects the comparison of 2021 results with 2020. Earnings per share attributable to Tootsie Roll Industries, Inc. for first quarter 2021 benefited from the reduction in average shares outstanding resulting from purchases in the open market by the Company of its common stock. Average shares outstanding decreased from 68,845 at first quarter 2020 to 67,852 at first quarter 2021.

Goodwill and intangibles, principally trademarks, are assessed annually as of December 31 or whenever events or circumstances indicate that the carrying values may not be recoverable from future cash flows. The Company has not identified any triggering events, as defined, or other adverse information that would indicate a material impairment of its goodwill or intangibles in first quarter 2021. The Company’s trademarks have indefinite lives and Company management believes that the adverse effects of the Covid-19 pandemic on net product sales are temporary and do not significantly affect our business model and long-term strategy. Therefore, we do not consider COVID-19 to be a triggering event to accelerate our annual impairments testing. There were no impairments in the comparative first quarter 2020 period or in calendar year 2020. Although Company management has not identified any trigging events at this time relating to its intangibles, the ultimate effects of the Covid-19 pandemic, including possible longer term effects on consumer lifestyles and behavior, could change this assessment in the future, as discussed below and as outlined in the Company’s risk factors discussed on Form 10-K for the year ended December 31, 2020.

Beginning in 2012, the Company received periodic notices from the Bakery, Confectionery, Tobacco Workers and Grain Millers International Union Pension Plan (Plan), a multi-employer defined benefit pension plan for certain Company union employees, that the Plan’s actuary certified the Plan to be in “critical status”, as defined by the Pension Protection Act (PPA) and the Pension Benefit Guaranty Corporation (PBGC); and that a plan of rehabilitation was adopted by the trustees of the Plan in 2012. Beginning in 2015, the Company received new annual notices that the Plan was reclassified to “critical and declining status”, as defined by the PPA and PBGC, for the plan year beginning January 1, 2015, and that the Plan was projected to have an accumulated funding deficiency for the 2017 through 2024 plan years. A designation of “critical and declining status” implies that the Plan is expected to become insolvent in the next 20 years. The Company has continued to receive annual notices each year (2016 to 2021) that this Plan remains in “critical and declining status” and is projected to become insolvent within the next 20 years. These notices have also advised that the Plan trustees were considering the reduction or elimination of certain retirement benefits and may seek assistance from the PBGC. Plans in “critical and declining status” may elect to suspend (or permanently) some benefits payable to all categories of participants, including retired participants, except retirees that are disabled or over the age of 80. Suspensions must be equally distributed and cannot drop below 110% of what would otherwise be guaranteed by the PBGC.

Based on these updated notices, the Plan’s funded percentage (plan investment assets as a percentage of plan liabilities), as defined, were 48.3%, 50.4%, and 51.6% as of the most recent valuation dates available, January 1, 2020, 2019, and 2018, respectively (these valuation dates are as of the beginning of each Plan year). These funded percentages are based on actuarial values, as defined, and do not reflect the actual market value of Plan investments as of these dates. If the market value of investments had been used as of January 1, 2020, the funded percentage would be 51.6% (not 48.3%). As of the January 1, 2020 valuation date (most recent valuation available), only 16% of Plan participants were current active employees, 53% were retired or separated from service and receiving benefits, and 31% were retired or separated from service and entitled to future benefits. The number of current active employee Plan participants as of January 1, 2020 fell 4% from the previous year and 17% over the past two years. When compared to the Plan valuation date of January 1, 2011 (nine years earlier), current active employee participants have declined 49%, whereas participants who were retired or separated from service and receiving benefits increased 4% and participants who were retired or separated from service and entitled to future benefits increased 12%.

The Company has been advised that its withdrawal liability would have been $99,300, $99,800 and $81,600 if it had withdrawn from the Plan during 2020, 2019 and 2018, respectively. The Company’s relative share of the Plan’s contribution base, driven by employer withdrawals, has increased for the last several years, and management believes that this trend could continue indefinitely which will continue to add upward pressure on the Company’s withdrawal liability. In addition, the overall reduction in interest rates in 2020, will increase the value of vested benefits and likely increase the Company’s withdrawal liability for 2021. Based on the above, including the Plan’s projected insolvency in the next 20 years, management believes that the Company’s withdrawal liability will likely increase in future years.

Based on the Company’s updated actuarial study and certain provisions in ERISA and the law relating to withdrawal liability payments, management believes that the Company’s liability would likely be limited to twenty annual payments of $2,958 which have a present value in the range of $34,700 to $49,300 depending on the interest rate used to discount these payments. While the Company’s actuarial consultant does not believe that the Plan will suffer a future mass withdrawal (as defined in the Plan) of participating employers, in the event of a mass withdrawal, the Company’s annual withdrawal payments would theoretically be payable in perpetuity. Based on the Company’s updated actuarial study, the present value of such perpetuities is in the range of $48,500 to $150,900 and would apply in the unlikely event that substantially all employers withdraw from the Plan. The aforementioned is based on a range of valuations and interest rates, which the Company’s actuary has advised is provided under the statute. Should the Company actually withdraw from the Plan at a future date, a higher withdrawal liability than the above discussed amounts, could be payable to the Plan.

The Company and the union concluded a new labor contract in 2018 which requires the Company’s continued participation in this Plan through September 2022. The amended rehabilitation plan, which also continues, requires that employer contributions include 5% compounded annual surcharge increases each year for an unspecified period of time beginning in 2012 as well as certain plan benefit reductions. In fourth quarter 2020, the Plan Trustees advised the Company that the surcharges would no longer increase and therefore be “frozen” at the rates and amounts in effect as of December 31, 2020 provided that the local bargaining union and the Company executed a formal consent agreement by March 31, 2021. The Trustees advised that they have concluded that continuing increases in surcharges would likely have a long-term adverse effect on the solvency of the Plan. The Trustees further concluded that additional increases would result in increasing financial hardships and withdrawals of participating employers, and that this change will not have a material effect on the Plan’s insolvency date. During first quarter 2021, the local bargaining union and the Company executed this agreement which resulted in the “freezing” of such surcharges as of December 31, 2020.

The Company’s pension expense for this Plan for first quarter 2021 and 2020 was $604 and $685, respectively ($2,866 and $2,961 for twelve months 2020 and 2019, respectively). The aforementioned expense includes surcharges of $213 and $241 for first quarter 2021 and 2020, respectively ($1,010 and $948 for twelve months 2020 and 2019, respectively), as required under the amended plan of rehabilitation.

Company Management understands that the U.S. American Rescue Plan Act of 2021 legislation passed in first quarter 2021 provides financial assistance to shore up struggling multi-employer plans for many future years. The Company continues to study this legislation to determine its effects on the Plan and Company withdrawal liability. The Company is currently unable to determine the ultimate outcome of the above discussed multi-employer union pension matter, including the effects of the American Rescue Plan legislation, and therefore is unable to determine the effects on its consolidated financial statements, but the ultimate outcome could be material to its consolidated results of operations or cash flows in one or more future periods. See also Note 7 in the Company’s Consolidated Financial Statements on Form 10-K for the year ended December 31, 2020.

The Company continues to actively monitor Covid-19 and its potential impact on our operations and financial results, prioritizing employee health and safety. Because the Company has a sizable investment in marketable securities (see Liquidity and Capital Resources section above) the Company continues to be well positioned financially to respond to any further adverse effects of this pandemic, and Covid-19 variants, in the short-term, as well as for a longer period of time if necessary.

LIQUIDITY AND CAPITAL RESOURCES

Net cash flows provided by operating activities were $15,337 and $14,581 in first quarter 2021 and 2020, respectively, a favorable increase of $756. The increase in first quarter 2021 cash flows from operating activities principally reflects changes in inventories partially offset by a decrease in accounts receivable which reflects the timing of net product sales and collections of accounts receivable trade, as well as changes in accounts payable and accrued liabilities, and income taxes payable in the comparative periods.

Net cash from (used in) investing activities was $(26,528) in first quarter 2021 compared to $8,261 in first quarter 2020. Cash flows used in investing activities reflect $30,031 and $21,312 of purchases of available for sale securities during first quarter 2021 and 2020, respectively, and $8,543 and $35,217 of sales and maturities of available for sale securities during first quarter 2021 and 2020, respectively. First quarter 2021 and 2020 investing activities include capital expenditures of $3,787 and $3,737, respectively. Company management has committed approximately $25,000 to a rehabilitation upgrade and expansion of one of its manufacturing plants in the U.S.A. The Company spent approximately $6,000 and $2,000 in 2020 and 2019, respectively. Company management expects cash outlays for this project to approximate $17,000 in 2021. All capital expenditures are to be funded from the Company’s cash flow from operations and internal sources including available for sale securities.

The Company’s consolidated financial statements include bank borrowings of $965 and $781 at March 31, 2021 and 2020, respectively, all of which relates to its Spanish subsidiary. The Company had no other outstanding bank borrowings at March 31, 2021.

Financing activities include Company common stock purchases and retirements of $7,423 and $8,809 in first quarter 2021 and 2020, respectively. Cash dividends of $11,874 and $11,703 were paid in first quarter 2021 and 2020, respectively.

The Company’s current ratio (current assets divided by current liabilities) was 4.4 to 1 at March 31, 2021 compared to 4.6 to 1 at December 31, 2020 and 4.3 to 1 at March 31, 2020. Net working capital was $226,391 at March 31, 2021 compared to $250,851 and $257,104 at December 31, 2020 and March 31, 2020, respectively. The aforementioned net working capital amounts are principally reflected in aggregate cash and cash equivalents and short-term investments of $178,687 at March 31, 2021 compared to $208,931 and $216,577 at December 31, 2020 and March 31, 2020, respectively. In addition, long term investments, principally debt securities comprising corporate bonds, were $243,749 at March 31, 2021, as compared to $220,020 and $153,287 at December 31, 2020 and March 31, 2020, respectively. Aggregate cash and cash equivalents and short and long-term investments were $422,436, $428,951, and $369,864, at March 31, 2021, December 31, 2020 and March 31, 2020, respectively. The aforementioned includes $78,271, $73,828, and $68,717 at March 31, 2021, December 31, 2020 and March 31, 2020, respectively, relating to trading securities which are used as an economic hedge for the Company’s deferred compensation liabilities. Investments in available for sale securities, primarily high quality corporate bonds, that matured during first quarter 2021 and 2020 were generally used to purchase the Company’s common stock or were replaced with debt securities of similar maturities.

The Company periodically contributes to a VEBA trust, managed and controlled by the Company, to fund the estimated future costs of certain employee health, welfare and other benefits. The Company is currently using these VEBA funds to pay the actual cost of such benefits through most of 2022. The VEBA trust held $7,543, $8,272 and $11,762 of aggregate cash and cash equivalents at March 31, 2021, December 31, 2020 and March 31, 2020, respectively. This asset value is included in prepaid expenses and long-term other assets in the Company’s Consolidated Statement of Financial Position. These assets are categorized as Level 2 within the fair value hierarchy.

ACCOUNTING PRONOUNCEMENTS

See Note 1 of the Company’s Condensed Consolidated Financial Statements.

FORWARD-LOOKING STATEMENTS

This discussion and certain other sections contain forward-looking statements that are based largely on the Company’s current expectations and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform

Act of 1995. Forward-looking statements can be identified by the use of words such as “anticipated,” “believe,” “expect,” “intend,” “estimate,” “project,” “plan” and other words of similar meaning in connection with a discussion of future operating or financial performance and are subject to certain factors, risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in the forward-looking statements. Such factors, risks, trends and uncertainties, which in some instances are beyond the Company’s control, include the overall competitive environment in the Company’s industry, changes in assumptions and judgments discussed above under the heading “Significant Accounting Policies and Estimates,” and factors identified and referred to above under the heading “Risk Factors” in this report and under the heading “Risk Factors” in the Company’s 2020 Form 10-K.

The risk factors identified and referred to above, including the effects of the Covid-19 pandemic and variants, are believed to be significant factors, but not necessarily all of the significant factors that could cause actual results to differ from those expressed in any forward-looking statement. Readers are cautioned not to place undue reliance on such forward-looking statements, which are made only as of the date of this report. The Company undertakes no obligation to update such forward-looking statements.

## Market risk

As filed, 1,161 characters.

The Company is exposed to various market risks, including fluctuations in and sufficient availability of sugar, corn syrup, edible oils, including palm oils, cocoa, dextrose, milk and whey, and gum-base input ingredients and packaging, and fuel costs principally relating to freight and delivery fuel surcharges. The Company is exposed to exchange rate fluctuations in the Canadian dollar which is the currency used for a portion of the raw material and packaging material costs and all labor, benefits and local plant operating costs at its Canadian plants. The Company is exposed to exchange rate fluctuations in Mexico, Canada, and Spain where its subsidiaries sell products in their local currencies. The Company invests in securities with maturities dates of up to approximately three years which are generally held to maturity, and variable rate demand notes where interest rates are generally reset weekly, all of which limits the Company’s exposure to interest rate fluctuations. There have been no material changes in the Company’s market risks that would significantly affect the disclosures made in the Form 10-K for the year ended December 31, 2020.

## Controls and procedures

As filed, 1,317 characters.

Under the supervision and with the participation of Management, the Chief Executive Officer and Chief Financial Officer of the Company have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2021 and, based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures are also designed to ensure that information is accumulated and communicated to Management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

There has been no change in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2021 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Filed May 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-005899. Last ingested by Listed: Nov 6, 2026, 15:19 ET. No prices; not investment advice.
